期刊
TRANSPLANT INTERNATIONAL
卷 25, 期 10, 页码 1013-1023出版社
WILEY
DOI: 10.1111/j.1432-2277.2012.01513.x
关键词
anemia; complications; erythrocytosis; immunosuppression; kidney clinical; transplantation
资金
- Amgen
Anemia is a highly prevalent disorder in recipients of renal allografts. Despite its frequent occurrence, there is still uncertainty with regard to treatment targets and treatment options. This includes questions on appropriate iron management, the choice and dosage of erythropoietin stimulating agents, criteria for the timing of treatment initiation and the targeted hemoglobin values. The review summarizes available data on recent therapeutic strategies for post-trasnplant anemia, as well as for post transplant erythrocytosis, another hematological disorder, that has decreased in recent years.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据